Skip to main content

Market Overview

18 Stocks Moving In Thursday's Pre-Market Session

Share:


Gainers

  • Inteliquent Inc (NASDAQ: IQNT) shares rose 37.4 percent to $23.00 in pre-market trading after the company agreed to be acquired by GTCR for $23.00 per share in cash.
  • Actua Corp (NASDAQ: ACTA) shares rose 23.7 percent to $14.35 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
  • Intersect ENT Inc (NASDAQ: XENT) rose 16.8 percent to $9.75 in pre-market trading after the company posted better-than-expected Q3 results.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose 16.3 percent to $3.22 in pre-market trading after the company disclosed its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis following successful completion of the end of Phase II meeting with the FDA.
  • Qiagen NV (NASDAQ: QGEN) shares rose 10.2 percent to $26.38 in pre-market trading on upbeat quarterly earnings.
  • Omeros Corporation (NASDAQ: OMER) shares rose 9.6 percent to $9.48 in pre-market trading after the company disclosed that it has filed orphan drug application for OMS721 in immunoglobulin A nephropathy
  • Insys Therapeutics Inc (NASDAQ: INSY) rose 9.2 percent to $11.26 in pre-market trading. Insys Therapeutics reported Q3 earnings of $0.00 per share on revenue of $55.2 million.
  • Technical Communications Corporation (NASDAQ: TCCO) rose 8.7 percent to $2.50 in pre-market trading after dropping 2.13 percent on Wednesday.
  • Royal Bank of Scotland Group PLC (NYSE: RBS) rose 7.7 percent to $4.87 in the pre-market trading session after falling 1.74 percent on Wednesday.
  • Depomed Inc (NASDAQ: DEPO) rose 7.2 percent to $24.10 in pre-market trading after declining 0.57 percent on Wednesday.
  • Chesapeake Energy Corporation (NYSE: CHK) rose 5.5 percent to $5.60 in the pre-market trading after the company reported upbeat quarterly earnings.
  • Whole Foods Market, Inc. (NASDAQ: WFM) rose 3.5 percent to $29.50 in pre-market trading after the company reported upbeat earnings for its fourth quarter. The company eliminated its co-CEO structure, and appointed John Mackey as sole CEO.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Diplomat Pharmacy Inc (NYSE: DPLO) shares fell 33.7 percent to $14.85 in pre-market trading after the company reported downbeat quarterly earnings and lowered its FY16 forecast.
  • Fitbit Inc (NYSE: FIT) shares fell 30 percent to $8.97 in pre-market trading after the company posted downbeat quarterly revenue and issued a weak forecast the current quarter.
  • Credit Suisse Group AG (ADR) (NYSE: CS) shares fell 4.9 percent to $12.92 in pre-market trading following Q3 results. Credit Suisse reported a profit of Sfr41 million ($42.25 million) for the quarter.
  • Facebook Inc (NASDAQ: FB) shares fell 4.9 percent to $120.91 in the pre-market trading session. Facebook posted better-than-expected earnings for its third quarter on Wednesday. However, the company’s CFO warned that revenue growth rates would decline in the fourth quarter.
  • First Solar, Inc. (NASDAQ: FSLR) fell 4.6 percent to $38.70 in pre-market trading after the company posted weak quarterly revenue and lowered its sales guidance.
  • GoPro Inc (NASDAQ: GPRO) shares fell 4.2 percent to $12.30 in pre-market trading. GoPro is expected to report quarterly earnings after the closing bell.
 

Related Articles (IQNT + ACTA)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com